SEER*Rx Interactive Antineoplastic Drugs Database

A drug administered to a patient for treatment, listed in SEER*Rx as a chemotherapeutic, hormonal or immunotherapy agent should be coded under chemotherapy [#1390], hormone therapy [#1400] or immunotherapy [#1410] regardless of the primary site(s) listed in SEER*Rx for that agent. Do not code under the data item, Other Therapy [NAACCR #1420]. Refer to the 2026 SEER manual for more information.

Search

• Drugs (1805)
• Regimen (458)
• Show 10 25 50 100 Entries

Name	Category	Primary Site	Code?
Vinrosidine Sulfate	Chemotherapy		Yes
Vinorelbine	Chemotherapy	Breast, lung cancer	Yes
Vinleurosine Sulfate	Chemotherapy		Yes
Vinglycinate Sulfate	Chemotherapy		Yes
Vinflunine	Chemotherapy	Bladder, breast, lung, other	Yes
Vinepidine Sulfate	Chemotherapy		Yes
Vindesine	Chemotherapy		Yes
Vincristine	Chemotherapy		Yes
Vinblastine	Chemotherapy		Yes
Vidaza	Chemotherapy	Myelodysplastic syndromes	Yes
Vidarabine	AIDS drug		No
Vibrio cholera neuraminidase	Biologic therapy (BRM, immunotherapy)		Yes
Verteporfin	Other therapy	Skin cancer	No
Verapamil	Ancillary Agent		No
Vendexta	Chemotherapy		Yes
Venclexta	Chemotherapy		Yes
Vemurafenib	Chemotherapy		Yes
Vaxid	Biologic therapy (BRM, immunotherapy)	Lymphoma	Yes
VaxSyn	AIDS drug		Yes
Vatalanib	Chemotherapy	brain, Colorectal, Myeloma, other cancer	Yes
Varubi	Ancillary Agent		No
Vapreotide	Chemotherapy		Yes
Vanflyta	Chemotherapy	Acute myeloid leukemia, AML	Yes
Vandetanib	Chemotherapy	Breast, cervical, endometrial, NSC lung cancer, ovarian, prostate, Thyroid	Yes
Vamidex	Chemotherapy	Colorectal, lung, other cancer, ovarian, pancreatic cancer	Yes

Name	Primary Site
Tam Exemestane
TT-R
TRAP
TPF
TPDCV
TPDC-FUHU
TPCH
TOAP
TIT
TIP
TIC
THP	Breast
TEMP
TEE
TCHP	Breast
TBP
TAXOL/CBDCA
TAD
TAC
T-MOP
T-CID
T-CAP
T-2 protocol
T-10 protocol
Stanford V